Paul Atkins, nominated by Trump, has been sworn in as SEC chair

Calypso Medical

company

About

Calypso Medical develops tumor localization systems designed to accurately and objectively track the location of tumors in human bodies.

  • 5001 - 10000

Details

Last Funding Type
Series D
Last Funding Money Raised
$42.20M
Industries
Health Care,Medical,Medical Device
Founded date
Oct 1, 1999
Number Of Employee
5001 - 10000
Operating Status
Active

Calypso Medical Technologies is a Seattle-based, privately held medical device company. The Company's proprietary tumor localization system utilizes miniaturized implanted devices (Beacon® electromagnetic transponders) to continuously, accurately and objectively track the location of tumors for improved accuracy and management of radiation therapy delivery. The technology is designed for body-wide cancers commonly treated with radiation therapy. The products are FDA 510(k) cleared for use in the prostate and post-operative prostatic bed. The Company has strategic relationships with Varian Medical Systems, Siemens Medical Systems, Elekta Corporation, and Philips Medical.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$49.04M
Calypso Medical has raised a total of $49.04M in funding over 2 rounds. Their latest funding was raised on Jan 8, 2007 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 8, 2007 Series D $42.20M 2 Apothecary Capital Detail
Jan 7, 2005 Series C $6.84M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Calypso Medical is funded by 2 investors. Apothecary Capital and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Apothecary Capital Yes Series D
Versant Ventures Series D